COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH A CD22 ANTIBODY-DRUG CONJUGATE

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP14721825.9

公开号：

EP2992015A1

申请日:

2014.04.30

申请国别(地区):

EP

年份:

2016

代理人:

摘要：

The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with a CD22 antibody-drug conjugate for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody and a CD22 antibody-drug conjugate.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/